Sabela Recalde
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
-
- Liver Diseases and Immunity
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Surgical Treatments 2
- Lung Cancer Research Studies 2
-
- Advanced Breast Cancer Therapies 4
- Lung Cancer Treatments and Mutations 2
- Brain Metastases and Treatment 2
- Co-authors
- Miguel Sampayo-Cordero (3 shared papers)Xavier González (3 shared papers)Agostina Stradella (6 shared papers)Jesús M. Bañales (1 shared paper)Jordi Ponce (2 shared papers)Antonio Llombart‐Cussac (3 shared papers)José Manuel Pérez García (1 shared paper)Manuel Ruíz‐Borrego (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical & Translational Oncology (2 papers)Annals of Oncology (2 papers)Modern Pathology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- SpainTaiwanSouth Korea
In The Last Decade
Sabela Recalde
14 papers receiving 58 citations
Peers
Comparison fields: 5 of 21
- Oncology 41
- Hepatology 10
- Reproductive Medicine 7
- Cancer Research 12
- Pulmonary and Respiratory Medicine 22
Countries citing papers authored by Sabela Recalde
This map shows the geographic impact of Sabela Recalde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabela Recalde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabela Recalde more than expected).
Fields of papers citing papers by Sabela Recalde
This network shows the impact of papers produced by Sabela Recalde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabela Recalde. The network helps show where Sabela Recalde may publish in the future.
Co-authors
The 25 scholars most cited alongside Sabela Recalde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 13 | |
| 2 | 2024 | 11 | |
| 3 | 2018 | 9 | |
| 4 | 2019 | 7 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2025 | 1 | |
| 9 | 2018 | 1 | |
| 10 | 2016 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2018 | 1 | |
| 13 | 2019 | 1 | |
| 14 | 2021 | 1 |
About Sabela Recalde
Sabela Recalde is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 14 papers that have together received 58 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), Colorectal Cancer Surgical Treatments (2 papers), Lung Cancer Treatments and Mutations (2 papers), Lung Cancer Research Studies (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Oncology (41 citations), Hepatology (10 citations), Reproductive Medicine (7 citations), Cancer Research (12 citations) and Pulmonary and Respiratory Medicine (22 citations). Sabela Recalde has collaborated with scholars based in Spain, Taiwan and South Korea. Frequent co-authors include Miguel Sampayo-Cordero, Xavier González, Agostina Stradella, Jesús M. Bañales, Jordi Ponce, Antonio Llombart‐Cussac, José Manuel Pérez García, Manuel Ruíz‐Borrego, Serafín Morales and January T. Salas. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Translational Oncology, Annals of Oncology, Modern Pathology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.